scispace - formally typeset
M

Michael Oelgeschläger

Researcher at Federal Institute for Risk Assessment

Publications -  22
Citations -  441

Michael Oelgeschläger is an academic researcher from Federal Institute for Risk Assessment. The author has contributed to research in topics: Embryonic stem cell & Cancer. The author has an hindex of 10, co-authored 22 publications receiving 342 citations.

Papers
More filters
Journal ArticleDOI

A prospective whole-mixture approach to assess risk of the food and chemical exposome

TL;DR: The proactive use of the likelihood of co-exposure, together with the new approach of methods-based testing, may be a timely and feasible way of identifying those substances and mixtures where hazards may have been overlooked and regulatory action is needed.
Journal ArticleDOI

A Bmp Reporter Transgene Mouse Embryonic Stem Cell Model as a Tool to Identify and Characterize Chemical Teratogens.

TL;DR: A bone morphogenetic protein (Bmp)-reporter ESC line, isolated from a well-characterized transgenic mouse line, is described as a new tool for the identification of chemical teratogens and the characterization of relevant mechanisms of embryonic toxicity.
Journal ArticleDOI

Restoring circadian synchrony in vitro facilitates physiological responses to environmental chemicals.

TL;DR: Investigating whether circadian synchronization of human cells in an in vitro system improves the cellular response and, thus, increases the sensitivity of the test system indicates that a synchronized circadian rhythm in a cell culture based test system can improve the physiological relevance of an appropriate in vitro method by reflecting the biological in vivo situation more closely.
Journal ArticleDOI

The E-Morph Assay: Identification and characterization of environmental chemicals with estrogenic activity based on quantitative changes in cell-cell contact organization of breast cancer cells.

TL;DR: The E-Morph Assay as discussed by the authors is a high-throughput screening-compatible image-based phenotypic screening assay that facilitates robust predictions of the estrogenic potential of environmental chemicals using quantitative changes in the cell-cell contact morphology of human breast cancer cells as a novel functional endpoint.